Showing results (271-280 of 523) with videos related to
Sort By:
Pageof 53
The Journal of Experimental Medicine|March 16, 2019
Secreted PD-L1 variants mediate resistance to PD-L1 blockade therapy in non-small cell lung cancerBo Gong, Kazuma Kiyotani, Seiji Sakata, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 12, 2023
Impact of Concurrent Genomic Alterations on Clinical Outcomes in Patients With ALK-Rearranged NSCLCLuis Lara-Mejía, Andres F Cardona, Luis Mas, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 18, 2015
Using Whole-Exome Sequencing to Identify Genetic Markers for Carboplatin and Gemcitabine-Induced ToxicitiesHenrik Gréen, Johanna Hasmats, Ilya Kupershmidt, et al.Clinical and Translational Radiation Oncology|May 19, 2023
Stereotactic body radiotherapy for extra-cranial oligoprogressive or oligorecurrent small-cell lung cancerAntonin Levy, Jonathan Khalifa, Etienne Martin, et al.International Journal of Radiation Oncology, Biology, Physics|March 16, 2026
Tumor purity as a prognostic and predictive biomarker of postoperative radiotherapy outcomes in stage IIIA-N2 non-small-cell lung cancer: a transcriptomic analysis from the Lung ART trialWael S Zrafi, Víctor Albarrán-Artahona, Filippo G Dall'Olio, et al.Lung Cancer (Amsterdam, Netherlands)|July 24, 2026
Impact of immunotherapy on overall survival and healthcare costs in advanced/metastatic lung cancer: A real-world study in FranceAdrien Rousseau, Astrid Foix-Colonier, Joël Luu, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|February 26, 2014
Is sacrifying the phrenic nerve during thymoma resection worthwhile?Sarah Hamdi, Olaf Mercier, Elie Fadel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2013
Detection of circulating tumor cells harboring a unique ALK rearrangement in ALK-positive non-small-cell lung cancerEmma Pailler, Julien Adam, Amélie Barthélémy, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2023
TROP2 Is Associated with Primary Resistance to Immune Checkpoint Inhibition in Patients with Advanced Non-Small Cell Lung CancerAlban Bessede, Florent Peyraud, Benjamin Besse, et al.Frontiers in Immunology|November 10, 2022
Immune-related arthritis following pelvic radiation therapy in a patient with lung cancer receiving long-term immune checkpoint blocker treatment: Case reportMihaela Aldea, Rakiba Belkhir, Emeline Colomba, et al.Pageof 53